CIK 0001360214
- Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450567010
- Phone
- +1 615-733-4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Financial Officer acquired 39,000 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 156,000 shares (option exercise)
- 4 Open-market sale Director sold 6,500 shares at $4.75 ($30,875)
- 4 Open-market sale Director sold 6,500 shares at $5.25 ($34,125)
- 4 Open-market sale Director sold 6,500 shares at $5.67 ($36,855)
- 4 Open-market sale Director sold 6,500 shares at $6.89 ($44,785)
- 4 Open-market sale Director sold 6,500 shares at $7.91 ($51,415)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 10,000 shares at $5.78 ($57,800)
- 4 Open-market sale Director sold 10,000 shares at $4.57 ($45,700)
- 4 Open-market sale Director sold 10,000 shares at $4.77 ($47,700)
- 4 Open-market sale Director sold 10,000 shares at $6.91 ($69,100)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 10,000 shares at $5.86 ($58,600)
Page 8 of 15 · 296 filings